Brompheniramine Maleate

马来酸溴苯那敏

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBrompheniramine Maleate
Drug Alias Name马来酸溴苯吡胺bromfeniramina溴苯吡丙胺brompheniraminum溴苯那敏 +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivityConjunctivitis, AllergicRhinitis, Allergic +[4
Global Approved IndicationsHypersensitivityConjunctivitis, AllergicRhinitis, Allergic
Approved Indications in ChinaRhinitis, Allergic
Original Approved Country/TerritoryUnited States
Original Approved Date1957/08/23
Country/TerritoryUnited StatesBrazilMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWyeth Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSupriya Lifescience Ltd
Active IndicationsRhinitis, Allergic
Inactive IndicationsHypersensitivityConjunctivitis, AllergicCommon Cold

Other Information

ATC CodeR06AB01